ロード中...
A113 COST SAVINGS OF SEROLOGIC VERSUS BIOPSY PROVEN DIAGNOSIS OF PEDIATRIC CELIAC DISEASE
BACKGROUND: Celiac disease (CD) affects approximately one percent of the population in Canada and the United States. At present, endoscopic diagnosis (ED) of CD remains the gold standard in North America, despite mounting evidence and validated European guidelines for serologic diagnosis (SD). Withi...
保存先:
| 出版年: | J Can Assoc Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7043441/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.112 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|